Instrumento Inactivo

Acciones OVERLAP NON REGR Euronext Paris

Acciones

Precio de cierre Euronext Paris Otros sitios de cotización
- ^EUR	-

Aeolus Pharmaceuticals Inc. Reports Unaudited Consolidated Earnings Results for the Third Quarter and Nine Months Ended June 30, 2013	14/08/13
Overlap : accède à la certification Oracle Platinium.	08/06/10
Overlap : premiers effets des mesures de réduction de coûts.	30/11/09
Overlap Groupe : baisse de 3% du CA au T4 08-09.	13/05/09
Overlap Groupe : Alto Invest au-dessus des 5% du capital.	07/04/09

Sector